Barclays
CATX icon

Barclays’s Perspective Therapeutics CATX Stock Holding History

Barclays’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$349K Buy
127,023
+104,976
+476% +$318K ﹤0.01% 3659
2026
Q2 		$75.2K Buy
22,047
+6,998
+47% +$26.4K ﹤0.01% 4172
2026
Q1 		$62.8K Sell
15,049
-77,742
-84% -$328K ﹤0.01% 4226
2025
Q4 		$255K Buy
92,791
+8,936
+11% +$25.5K ﹤0.01% 4197
2025
Q3 		$288K Sell
83,855
-19,426
-19% -$70.8K ﹤0.01% 4130
2025
Q2 		$355K Buy
103,281
+45,388
+78% +$120K ﹤0.01% 3949
2025
Q1 		$123K Sell
57,893
-36,986
-39% -$111K ﹤0.01% 4316
2024
Q4 		$303K Sell
94,879
-19,196
-17% -$157K ﹤0.01% 4116
2024
Q3 		$1.52M Buy
114,075
+97,493
+588% +$1.3M ﹤0.01% 3072
2024
Q2 		$165K Buy
16,582
+9,681
+140% +$140K ﹤0.01% 3675
2024
Q1 		$82.1K Buy
+6,901
New +$58.8K ﹤0.01% 4502
2021
Q2 		– Sell
-174
Closed -$2K – 4882
2021
Q1 		$2K Buy
+174
New +$2.63K ﹤0.01% 4552
2018
Q2 		– Hold
0
– – – 6986
2018
Q1 		– Hold
0
– – – 7070

Other funds holding CATX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nicholson Wealth Management Group
Nicholson Wealth Management Group Charlestown, South Carolina $168M AUM 6.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hills Bank & Trust
Hills Bank & Trust North Liberty, Iowa $2.37B AUM 11.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Barclays's CATX Position: Q3 2026 in Review

Barclays increased its Perspective Therapeutics (CATX) stake by 476% in Q3 2026, buying an estimated $318K and bringing the position to 127,023 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #3659.

Barclays first reported a position in CATX in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.52M in Q3 2024. 42 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • Barclays held 127,023 shares of Perspective Therapeutics worth $349K as of Q3 2026.
  • Barclays bought 104,976 Perspective Therapeutics shares in Q3 2026, an estimated $318K.
  • Perspective Therapeutics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3659 holding.
  • Barclays first reported a position in Perspective Therapeutics in Q1 2021 and has held it in 12 quarters since.
  • Barclays's Perspective Therapeutics position peaked at $1.52M in Q3 2024.
  • 42 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.